Cargando…

Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) is the main histologic form of lung cancer that affects human health, but biomarkers for therapeutic diagnosis and prognosis of the disease are currently lacking. MATERIAL/METHODS: The gene expression profile GSE18842 was downloaded from the Gene Expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xingyuan, Liu, Xuefeng, Li, Jingyuan, Ren, Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Special Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911305/ https://www.ncbi.nlm.nih.gov/pubmed/31805030 http://dx.doi.org/10.12659/MSM.918620

Ejemplares similares

Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis
por: Gong, Ke, et al.
Publicado: (2021)

Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis
por: Yu, Liyan, et al.
Publicado: (2023)

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis
por: Ni, Mengwei, et al.
Publicado: (2018)

Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma
por: Li, Jingyuan, et al.
Publicado: (2020)

Bioinformatics analysis reveals 6 key biomarkers associated with non-small-cell lung cancer
por: Dai, Bai, et al.
Publicado: (2019)

Identification of key candidate tumor biomarkers in non-small-cell lung cancer by in silico analysis
por: Chen, Weiping, et al.
Publicado: (2020)

Screening and identification of biomarkers associated with the diagnosis and prognosis of lung adenocarcinoma
por: Wang, Yanyun, et al.
Publicado: (2020)

Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis
por: Liu, Huanqing, et al.
Publicado: (2021)

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer
por: Tang, Yong, et al.
Publicado: (2017)

Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis
por: Liu, Shuyu, et al.
Publicado: (2020)

Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis
por: Wu, Qiong, et al.
Publicado: (2019)

The key to immunotherapy: how to choose better therapeutic biomarkers for patients with non-small cell lung cancer
por: Pan, Yue, et al.
Publicado: (2022)

Transcriptome Based Estrogen Related Genes Biomarkers for Diagnosis and Prognosis in Non-small Cell Lung Cancer
por: Jia, Sinong, et al.
Publicado: (2021)

Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis
por: Li, Jinghang, et al.
Publicado: (2020)

Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer
por: Ren, Sai, et al.
Publicado: (2023)

Identification of candidate biomarkers correlated with the diagnosis and prognosis of cervical cancer via integrated bioinformatics analysis
por: Dai, Fangfang, et al.
Publicado: (2019)

Identification of Key Genes and FUNCTIONAL Pathway in Radioresistance of Non-Small Cell Lung Cancer
por: Li, Shouying, et al.
Publicado: (2022)

Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis
por: Zhang, Xintong, et al.
Publicado: (2022)

Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
por: Lai, Li-Ting, et al.
Publicado: (2023)

Bioinformatics and integrated analyses of prognosis-associated key genes in lung adenocarcinoma
por: Zhu, Huijun, et al.
Publicado: (2021)

Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis
por: Dai, Gong-Peng, et al.
Publicado: (2020)

Identification of faecal extracellular vesicles as novel biomarkers for the non‐invasive diagnosis and prognosis of colorectal cancer
por: Zhang, Zhaowei, et al.
Publicado: (2023)

Serum tumour M2‐pyruvate kinase as a biomarker for diagnosis and prognosis of early‐stage non–small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2021)

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
por: Akamatsu, Hiroaki, et al.
Publicado: (2019)

Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma
por: Ma, Xiaohan, et al.
Publicado: (2020)

Treatment for non-small-cell lung cancer and circulating tumor cells
por: Mason, Joel, et al.
Publicado: (2017)

Identification of plasma exosomes long non-coding RNA HAGLR and circulating tumor cells as potential prognosis biomarkers in non-small cell lung cancer
por: Rao, Le, et al.
Publicado: (2019)

Identification of Prognostic Gene Biomarkers in Non-Small Cell Lung Cancer Progression by Integrated Bioinformatics Analysis
por: Giannos, Panagiotis, et al.
Publicado: (2021)

Identification and validation of key genes with prognostic value in non‐small‐cell lung cancer via integrated bioinformatics analysis
por: Wang, Li, et al.
Publicado: (2020)

Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer
por: Xie, Yujiao, et al.
Publicado: (2018)

Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer
por: Shen, Lei, et al.
Publicado: (2017)

Identification of key genes in non-small cell lung cancer by bioinformatics analysis
por: Zhang, Li, et al.
Publicado: (2019)

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
por: Garrido, P., et al.
Publicado: (2019)

New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
por: Isla, Dolores, et al.
Publicado: (2022)

Bioinformatics Identification of Key Genes for the Development and Prognosis of Lung Adenocarcinoma
por: Luo, Xuan, et al.
Publicado: (2022)

Identification of Circulating Long Noncoding RNA HOTAIR as a Novel Biomarker for Diagnosis and Monitoring of Non–Small Cell Lung Cancer
por: Li, Nandi, et al.
Publicado: (2017)

Identification of key claudin genes associated with survival prognosis and diagnosis in colon cancer through integrated bioinformatic analysis
por: Alghamdi, Rana A., et al.
Publicado: (2023)

Identification of Ferroptosis-Related Biomarkers for Prognosis and Immunotherapy in Patients With Glioma
por: Shi, Junfeng, et al.
Publicado: (2022)

Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis
por: Cui, Shengjin, et al.
Publicado: (2022)

Serum midkine as non-invasive biomarker for detection and prognosis of non-small cell lung cancer
por: Stern, Louisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lhrsjhilie7m83ngt5v1bql5tl